📊 Score Breakdown
Offering Ability
40
Cash Runway
65
Float Risk
12
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
35%
🔄 Reverse Split
40%
• 50-day avg $1.68 approaching $1 threshold
• 11 months cash with weak price
📉 Score Deterioration
40%
• Score rose 26 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (11mo)
💹 Market Data
Market Cap$467.16M
Shares Outstanding338.52M
Float316.86M
Cash$31.86M
Debt$33.30M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 25.6% shares (2025Q4 vs prior)
110 institutional holders · 62.08M shares
#1
VANGUARD GROUP INC
16.48M shares
#2
MILLENNIUM MANAGEMENT LLC
5.40M shares
#3
UBS Group AG
4.85M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest81.05M
Days to Cover8.2
% of Float25.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2022
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for OCGN
📊 OCGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 OCGN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.